Online test - Screening for Oral Cancer

Screening for Oral Cancer

To take the following test, check the answer which you think best fits the question. Please fill out your NAME, EMAIL ADDRESS, and PHONE number for identification purposes. When all of the information is filled out, and you have finished taking the test, click on the SUBMIT button at the bottom of the quiz. Your test results will then be sent to the ADHA, and you will be notified of your score within a few days.
Good Luck!

For identification purposes, please fill out the following:

Name:
Email Address:
Phone:

1. The prognosis for oral cancer depends upon when the cancer is diagnosed. Late detection of oral cancer increases the potential for mortality.

	A. Both statements are true
	B. Both statements are false
	C. The first statement is true, the second statement is false
	D. The first statement is false, the second statement is true

2. Early presentations of oral cancer include color changes and pain.

	A. True
	B. False

3. The majority of oral cancers are:

	A. Mucoepidermoid carcinoma
	B. Basal cell carcinoma
	C. Verrucous carcinoma
	D. Squamous cell carcinoma

4. The most common risk factors for oral and pharyngeal cancers are:

	A. HPV and tobacco use
	B. HIV and HPV
	C. Alcohol and tobacco use
	D. Family history of cancer and tobacco use

5. An example of chemiluminscent technology for the detection of oral cancer is:

	A. OralCDx® Brush test®
	B. ViziLite® Plus with TBlue®
	C. VELscope®
	D. Identafi®
	E. a and b
	F. b and c
	G. c and d

6. An example of autofluorescence technology for the detection of oral cancer is:

	A. OralCDx® Brush test®
	B. ViziLite® Plus with TBlue®
	C. VELscope®
	D. Identafi®
	E. a and b
	F. b and c
	G. c and d

7. An example of technology that uses computer-based imaging to rank the cells on the basis of abnormal morphology is:

	A. OralCDx® Brush test®
	B. ViziLIte® Plus with TBlue®
	C. VELscope®
	D. Identafi®
	E. a and b
	F. b and c
	G. c and d

8. The probability that a person having a disease will be correctly identified by a clinical test refers to:

	A. Sensitivity
	B. Specificity
	C. Positive predictive value
	D. Negative predictive value

9. One of the advantages of adjunctive devices over the COE is that they can distinguish between benign, premalignant, and malignant diseases.

	A. True
	B. False

10. The strongest research supporting its efficacy is found in which adjunctive device?

	A. OralCDx® Brush test®
	B. Vizilite® Plus with TBlue®
	C. VELscope®
	D.Identafi®
	E.All of the above
	F.None of the above

11. Improving oral cancer detection can be accomplished through:

	A. Performing a COE on every patient
	B. Teaching patients to perform an oral cancer self-examination
	C. Using adjunctive screening devices
	D. a and b
	E. b and c
	F. a, b, and c

12. Reasons why a COE are NOT routinely performed by oral health professionals include:

	A. Lack of knowledge about the procedure
	B. Lack of knowledge about detecting abnormalities
	C. Disbelief that a COE is needed
	D. a and b
	E. b and c
	F. a,b, and c

13. Performing a COE on patients is part of the standards of care for dental hygiene practice. Dental hygienists can augment the COE with adjunctive screening devices based on the patient’s risk factors and scientific evidence.

	A. Both statements are true
	B. Both statements are false
	C.The first statement is true, the second statement is false
	D.The first statement is false, the second statement is true

14. Safety is a factor to consider when determining which adjunctive oral cancer screening device to use in practice. Only the OralCDx® Brush test® and the ViziLite® Plus with TBlue® have demonstrated safety standards sufficient for private practice settings.

	A. Both statements are true
	B. Both statements are false
	C.The first statement is true, the second statement is false
	D.The first statement is false, the second statement is true

15. Healthy People 2020 has targeted what percent of patients to have a routine COE on an annual basis?

	A. 10%
	B. 20%
	C. 30%
	D. 40%